|
⚲
|
| Keyboard |
| Sensenig Bethany
✚
|
|
|---|---|
| CIK # | 0001899935 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001899935] | |
| 4 | [0001899935] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sensenig Bethany | |
| KalVista Pharmaceuticals Inc | |
| Alpha Cognition Inc | |
| Supernus Pharmaceuticals Inc | |
| 9 Meters Biopharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2026-02-19 | Option exercise | 4,475 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-02-19 | Option exercise | 4,475 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-02-19 | Sell | 3,258 | $51.27 | 167,038 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-02-19 | Sell | 1,217 | $50.31 | 61,227 |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2026-02-18 | Grant | 4,977 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2026-02-18 | Grant | 2,989 | $0.00 | |
|
KalVista Pharmaceuticals Inc KALV
Stock Option (right to buy) · derivative
|
2025-10-01 | Grant | 45,000 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2025-08-14 | Sell | 5,369 | $42.25 | 226,840 |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2025-02-22 | Disposed to issuer | 5,369 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2025-02-22 | Grant | 5,369 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2025-02-19 | Grant | 7,296 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2025-02-19 | Grant | 4,475 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2024-02-22 | Grant | 5,369 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2024-02-22 | Grant | 8,252 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2023-08-17 | Grant | 24,153 | $0.00 | |
|
9 Meters Biopharma Inc NMTR
Common stock
|
2023-04-21 | Sell | 9,100 | $1.21 | 11,011 |
|
9 Meters Biopharma Inc NMTR
Common Stock
|
2023-03-27 | Grant | 50,177 | ||
|
9 Meters Biopharma Inc NMTR
Stock Option (Right to Buy) · derivative
|
2022-01-18 | Grant | 1,300,000 | $0.00 |